Sunday, 26 January 2020

Korea News

  • Teva to buy Korea's Celltrion?

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 18 Oct, 2016

    Singapore: With a view to strengthen its biosimilars portfolio, Isreali drug giant Teva pharmaceuticals said that it may consider acquiring Korean biosimilar giant Celltrion . "We will con...Read more

  • South Korea's Hanmi pharmaceuticals in troubled waters!

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 14 Oct, 2016

    Singapore: New blockbuster cancer drug from South Korea's Hanmi pharmaceuticals is in troubled waters after a patient died of a severe skin-related side effect linked to the drug's use. Ha...Read more

  • Korea's Hanmi inks deal with Roche's Genetech

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 30 Sep, 2016

    Singapore: South Korea's Hanmi Pharmaceutical has inked a deal with Roche's Genentech (to develop and commercialize Hanmi's pan-RAF inhibitor, Phase 1-stage HM95573. HM95573 is a pan-RAF in...Read more

  • GE opens Bioprocessing Technology and Training Center in South Korea

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 29 Sep, 2016

    Singapore: GE Healthcare's Life Sciences business has announced the opening of a GE Fast Trak Center in Songdo, Incheon Metropolitan City, South Korea. The new $7.4 million Center will supp...Read more

  • Thermo Fisher Scientific opens new clinical services facility in Korea

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 19 Sep, 2016

    Singapore: With a view to address the growing demand in clinical services, Thermo Fisher Scientific has opened a new clinical services facility in South Korea. Located in Seoul, the new sit...Read more

  • Roche Korea apppoints a new GM

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 26 Apr, 2016

    Singapore: Swiss pharma giant Roche recently appointed Mr Matt Sause as the new general manger for its Korean branch. Mr Sause was the former chief of Roche Pharma Peru. He was also the for...Read more

  • Koreans to wear Zika-proof uniforms in the Olympics

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 29 Apr, 2016

    Singapore: With the international Olympic games alls et to kick off in Brazil this year, South Korea has invented new Zika-proof uniforms for its athletes that are infused with insect repel...Read more

  • CEVEC, Yuhan sign deal for immortalized cell lines

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 20 Dec, 2012

    Singapore: CEVEC Pharmaceuticals, the developer of a novel human expression system derived from amniocytes, and Yuhan, a leading manufacturer of pharmaceutical products based in Seoul, Sou...Read more

  • Samsung's Humira biosimilar accepted for review by EU

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2016

    Singapore: Korean drug giant Samsung Bioepis, recently revealed that it is seeking regulatory approval in Europe to sell its copy of AbbVie Inc's rheumatoid arthritis drug Humira. The compa...Read more

  • Daiichi Sankyo inks marketing pact with Daewoong Pharmaceutical

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 29 Dec, 2015

    Singapore: Daiichi Sankyo Company has announced that its wholly owned subsidiary, Daiichi Sankyo Korea and Daewoong Pharmaceutical have signed an agreement for the co-promotion of the oral,...Read more

  • China Cord Blood, Cordlife join hands for stem cell therapy services

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2014

    Singapore: China Cord Blood Corporation (CCBC) and Cordlife Group, a multi-product healthcare company catering to the mother and child segment, have come together to assist patients across ...Read more

  • Korea to nurture pharma sector with capital assistance

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 06 Feb, 2015

    Singapore: The Korean Ministry of health and welfare have announced the start of second phase of Global Pharmaceutical Industry Development Fund worth 135 billion won (US$123 million) to nu...Read more

  • Amgen to acquire rights of three drugs from GSK

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 16 Dec, 2015

    Singapore: Global pharmaceutical company, Amgen, has plans to reacquire all of its remaining rights from GSK on Prolia (denosumab), XGEVA (denosumab) and Vectibix (panitumumab) in 48 countr...Read more

  • Asia's lung cancer burden

    Korea |  Analysis | By BioSpectrum Bureau  | 0 Comment | 08 Apr, 2016

    Lung cancer occurs in two types, small cell lung cancer and the more prevalent non-small scale lung cancer. According to oncology specialists' analysis, 85 percent of the lung cancer patien...Read more

  • Biosimilars to push growth in China, Korea, India

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 05 Oct, 2012

    Singapore: The annual revenue for biopharmaceuticals has been consistently growing since 2001, accounting for 15.6 percent of the total pharmaceutical market in 2011. The global biopharmac...Read more

  • Bayer Korea appoints a new CEO

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 27 Jan, 2015

    Singapore: Bayer Korea recently announced the appointment of Ms Ingrid Drechsel as its new CEO. The company said in a statement that Ms Drechsel will manage Bayer's business units in Korea ...Read more

  • TWi Biotech secures patent for diabetes drug in Korea

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 28 Oct, 2015

    Singapore: Taiwan based TWi Biotechnology has been granted patent in Korea for it diabetes drug, AC-201, from the Korean Intellectual Property Office. The patent includes AC-201 or its pha...Read more

  • Korea's Green cross expands cell therapy business in China

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 12 Mar, 2015

    Singapore: South Korean biopharmaceutical company, Green Cross, is expanding its presence in China by building a cell therapy facility to produce and distribute cell therapy products in the...Read more



Survey Box

Is 2020 demanding timely action of technology adoption in healthcare?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls